Annual Conference

2022-Virtual-Conference-Page-Header-Call-for-Abstracts

Now Open! Call for Abstracts for the General Poster Session

NCCN welcomes original abstracts from investigators in the general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Participants from both NCCN and non-NCCN Member Institutions may submit abstracts.

The NCCN General Poster Session, including submission review, is overseen by the NCCN Oncology Research Program (ORP). The submission deadline is Wednesday, November 10, 2021, 11:59 pm ET. Corresponding authors can expect to receive notification via e-mail in mid-December 2021.

SUBMIT ABSTRACT


Save the Dates!

NCCN 2022 Annual Conference
Thursday, March 31, 2022 – Saturday, April 2, 2022

NCCN 2022 Nursing Program: Advancing Oncology Nursing™
Wednesday, March 30, 2022

NCCN 2022 Oncology Fellows Program: New Horizons in Quality Cancer Care
Wednesday, March 30, 2022


NCCN 2022 Annual Conference Update


NCCN remains committed to lessening the transmission risk of COVID-19 and continues to monitor and follow the guidelines and recommendations provided by the Centers for Disease Control and Prevention, as well as local and state health agencies, related to conducting live meetings and events. Information provided by these agencies could result in modifications, restrictions, or even the cancellation of live events or certain functions. 

At this time, NCCN is planning for the Conference and related activities to be held as “hybrid” events on March 30 – April 3, 2022 to include live (in-person) and a virtual option. The live sessions will be held at the Rosen Shingle Creek, Orlando, FL and simultaneously, we will provide a virtual platform where certain activities/sessions will be offered for remote attendance. 

Should plans change, we will make every effort to communicate updated information as quickly and efficiently as possible. Please check back for additional updates. 


More than 35 recorded educational sessions from the NCCN 2021 Virtual Annual Conference are now available! 

View topics below or visit education.nccn.org/ac2021 for more information.

Keynote Sessions

Best Practices in Oncology

Breast Cancer


Cutaneous Melanoma


Gastrointestinal Cancers

Genitourinary Cancers

Gynecological Malignancies

Head and Neck Cancers


Hematologic Malignancies

Non-Small Cell Lung Cancer

Supportive Care/Survivorship


Other Topics

 

Additional activities

 

This activity is supported by educational grants from:

  • Abbott's molecular business
  • Adaptive Biotechnologies
  • AstraZeneca
  • BeiGene, Ltd.
  • Blueprint Medicines
  • Daiichi Sankyo
  • Deciphera Pharmaceuticals
  • Eisai
  • Exact Sciences
  • Genentech, a member of the Roche Group
  • Gilead Sciences
  • GlaxoSmithKline
  • GRAIL, Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Jazz Pharmaceuticals, Inc.
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
  • Lilly
  • Olympus Corporation of the Americas
  • Novartis
  • Pfizer
  • Puma Biotechnology
  • Seagen Inc. formerly Seattle Genetics
  • Taiho Oncology, Inc.
  • TeSera Therapeutics

 

This activity is supported by independent medical education grants from: 

  • Bristol Myers Squibb
  • Illumina, Inc.
  • Regeneron Pharmaceuticals, Inc and Sanofi Genzyme

 

This activity is supported by independent educational grants from:

  • AbbVie
  • Astellas
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Incyte
  • Merck & Co., Inc.

 

This activity is supported by educational funding provided by Amgen.

This educational activity is supported by a medical education grant from Exelixis, Inc. & Karyopharm® Therapeutics.

This project has been made possible in part by a grant from Varian Medical Systems/Global Medical Education Grant Program.

View abstracts from the NCCN 2021 Virtual Annual Conference in JNCCN-Journal of the National Comprehensive Cancer Network.

More than 90 posters were accepted to participate in the NCCN Virtual Poster Exhibition Hall throughout the following categories.  

  • Clinical Oncology (all phases)
  • Epidemiology/Risks/Prevention
  • Best Practices in Implementation and Use of Clinical Practice Guidelines
  • Quality Improvement
  • Outcomes and Health Services Research
  • Bioinformatics/Information Technology Sciences

The virtual event included the NCCN Virtual Exhibition Hall, the Reimbursement Resource Room, and Patient Advocacy Pavilion.

View Exhibition Guide

 

Platinum Level Sponsors

Eisai Inc.
GSK
Incyte

Gold Level Sponsors

Janssen Oncology
Pharmacyclics LLC., an AbbVie Company

Silver Level Sponsor

Regeneron Pharmaceuticals

Bronze Level Sponsors

AstraZeneca
BeiGene
Jazz Pharmaceuticals
Sanofi Genzyme
Servier

 

NCCN Patient Advocacy Pavilion Sponsors

Ruby

Pharmacyclics

Emerald

AstraZeneca
BeiGene, Ltd.
Coherus BioSciences
Eisai Inc.
Gilead-Kite Oncology
Incyte
Janssen
Karyopharm Therapeutics Inc.
Oncopeptides

Topaz

AbbVie
AmerisourceBergen
GSK
Natera
Novartis

Jade

Servier
Takeda
TG Therapeutics